Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02403856
Other study ID # RC15_0019
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date April 4, 2015
Est. completion date November 13, 2017

Study information

Verified date October 2018
Source Nantes University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Calcific tendinitis of the rotator cuff is a common cause of chronic pain of the shoulder. Needling and lavage of the calcification is one of the therapeutic options after failure of conservative management with physiotherapy and anti-inflammatory drugs. Needling is usually followed by a corticosteroid injection in the subacromial bursae in order to prevent acute pain reaction due to the intervention. However, the relevance of this injection has never been proven. Moreover, corticosteroid could prevent the inflammatory reaction induced by the needling and thus the body's natural calcium resorption processes. Finally, corticosteroids could have deleterious effect on the tendon structures and favour local infection. Our hypothesis is that corticosteroid have no significant effect on acute pain after needling and therefore should not been performed systematically after needling.


Recruitment information / eligibility

Status Completed
Enrollment 136
Est. completion date November 13, 2017
Est. primary completion date April 2, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Shoulder pain for at least 3 month

- Positive Hawkins, Yocum and/or Neer test for impingement

- Calcific deposit >= 5 mm on shoulder x-ray in one the tendon of the rotator cuff

Exclusion Criteria:

- Allergy to lidocaïne or methylprednisolone acetate

- Acute pain suggestive of resorption of the calcification with ill-defined - calcification on X-Ray

- Other shoulder diseases : ostearthritis of the gleno-humeral or acromio-clavicular joint

- Sonographic findings of rotator cuff tear

- Subacromial steroid injection in the previous month

- Uncontrolled diabetes

- Pregnant women

- Contraindication for the use of nonsteroidal antiinflammatory drugs or paracetamol/acetaminophene

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Sodium Chloride 0.9%
Needling and lavage of calcific tendinitis of the rotator cuff followed by the injection of sterile physiological Saline (Sodium Chloride 0.9%) in the subacromial bursae.
Methylprednisolone acetate
Needling and lavage of calcific tendinitis of the rotator cuff followed by the injection of methylprednisolone acetate in the subacromial bursae
Procedure:
Ultrasound-guided Needling and Lavage


Locations

Country Name City State
France La Roche sur Yon Hospital La Roche sur Yon
France Nantes University Hospital Nantes
France Rennes University hospital Rennes

Sponsors (1)

Lead Sponsor Collaborator
Nantes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maximum pain (VAS scale) Maximum pain on a VAS scale (0-10) reported by the patient in the seven days following the needling. 7 days
Secondary Anti-inflammatory and analgesic intake 7 days
Secondary Size of the calcific deposit 7 days
Secondary Size of the calcific deposit 3 months
Secondary Size of the calcific deposit 12 months
Secondary Number of frozen shoulder in each group 7 days
Secondary Number of frozen shoulder in each group 6 weeks
Secondary Number of frozen shoulder in each group 3 months
Secondary Number of frozen shoulder in each group 6 months
Secondary Number of frozen shoulder in each group 12 months
Secondary VAS pain during daily activity 7 days
Secondary VAS pain during daily activity 6 weeks
Secondary VAS pain during daily activity 3 months
Secondary VAS pain during daily activity 6 months
Secondary VAS pain during daily activity 12 months
Secondary VAS pain at rest 7 days
Secondary VAS pain at rest 6 weeks
Secondary VAS pain at rest 3 months
Secondary VAS pain at rest 6 months
Secondary VAS pain at rest 12 months
Secondary The Disabilities of the Arm, Shoulder and Hand (DASH) Score 7 days
Secondary The Disabilities of the Arm, Shoulder and Hand (DASH) Score 6 weeks
Secondary The Disabilities of the Arm, Shoulder and Hand (DASH) Score 3 months
Secondary The Disabilities of the Arm, Shoulder and Hand (DASH) Score 6 months
Secondary The Disabilities of the Arm, Shoulder and Hand (DASH) Score 12 months